Grant: Master's Award: Canada Graduate Scholarships
University of British Columbia
$17,500.00
Role of Granzyme B in microvascular dysfunction
EF 2013-14
Résumé
83% of all health care spending in the United States is allocated towards people with chronic disorders. These include heart disease, arthritis and diabetes, just to name a few. Most, if not all, of these disorders persists due to chronic inflammation. After an initial injury or infection, your body sends immune cells to the site of infection, causing inflammation. If this inflammation is not regulated properly we are left with chronic inflammation. Chronic inflammation is responsible for the production of a variety of enzymes. These enzymes breakdown the infrastructure of the local tissue, and disrupts the local blood flow which is necessary for repair. These breakdowns further signal the body that there is disruption in this site causing more immune cells to be recruited to the site, hence constantly sustaining inflammation and sustaining the disease itself.
One of the enzymes that is consistently present in the infrastructure of these inflamed tissues is Granzyme B (GzmB). We believe GzmB plays a key role in maintaining this chronic inflammation. We have already shown GzmB is responsible in breaking down the infrastructure of the tissue, and in this way destroys the tissue causing further inflammation. And we have recently shown that GzmB could possess characteristics implicated in local blood flow disruptions. My study will test this hypothesis in mice models. I will be involved in studying whether GzmB indeed disrupts the local blood flow, and thereby disrupts the tissue repair process. This study will further clarify the role of GzmB in chronic inflammation. Based on my results we could provide a rationale for drug production that could inhibit the activity of GzmB in chronic inflammatory diseases. GzmB is proving to play a pivotal role in chronic inflammation and with over 40% of the population in the US suffering from some form of chronic disorder, treatment of chronic inflammatory diseases is much needed in our health care system.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
311795
Name
Sharma Mehul
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Role of Granzyme B in microvascular dysfunction
Programtype2
Studentship Programs
Orgnameinp2
University of British Columbia
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Angiogenesis; Blood Vessel Leakage; Chronic Inflammation; Extra-Cellular Matrix; Granzyme B; Microvasculature; Pathology; Tissue Integrity; Vegf; Wound Healing
Abstract
83% of all health care spending in the United States is allocated towards people with chronic disorders. These include heart disease, arthritis and diabetes, just to name a few. Most, if not all, of these disorders persists due to chronic inflammation. After an initial injury or infection, your body sends immune cells to the site of infection, causing inflammation. If this inflammation is not regulated properly we are left with chronic inflammation. Chronic inflammation is responsible for the production of a variety of enzymes. These enzymes breakdown the infrastructure of the local tissue, and disrupts the local blood flow which is necessary for repair. These breakdowns further signal the body that there is disruption in this site causing more immune cells to be recruited to the site, hence constantly sustaining inflammation and sustaining the disease itself.
One of the enzymes that is consistently present in the infrastructure of these inflamed tissues is Granzyme B (GzmB). We believe GzmB plays a key role in maintaining this chronic inflammation. We have already shown GzmB is responsible in breaking down the infrastructure of the tissue, and in this way destroys the tissue causing further inflammation. And we have recently shown that GzmB could possess characteristics implicated in local blood flow disruptions. My study will test this hypothesis in mice models. I will be involved in studying whether GzmB indeed disrupts the local blood flow, and thereby disrupts the tissue repair process. This study will further clarify the role of GzmB in chronic inflammation. Based on my results we could provide a rationale for drug production that could inhibit the activity of GzmB in chronic inflammatory diseases. GzmB is proving to play a pivotal role in chronic inflammation and with over 40% of the population in the US suffering from some form of chronic disorder, treatment of chronic inflammatory diseases is much needed in our health care system.
Competitiondate
201312
Approvedterm2
1 yr 0 mth
Pinamesdelim
Sharma, Mehul
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~